Correlation Between Alto Neuroscience, and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Candel Therapeutics, you can compare the effects of market volatilities on Alto Neuroscience, and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Candel Therapeutics.
Diversification Opportunities for Alto Neuroscience, and Candel Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alto and Candel is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Candel Therapeutics
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Alto Neuroscience, is 2.87 times less risky than Candel Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 451.00 in Candel Therapeutics on December 3, 2024 and sell it today you would earn a total of 340.00 from holding Candel Therapeutics or generate 75.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Alto Neuroscience, vs. Candel Therapeutics
Performance |
Timeline |
Alto Neuroscience, |
Candel Therapeutics |
Alto Neuroscience, and Candel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alto Neuroscience, and Candel Therapeutics
The main advantage of trading using opposite Alto Neuroscience, and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.Alto Neuroscience, vs. Best Buy Co | Alto Neuroscience, vs. Titan Machinery | Alto Neuroscience, vs. Tradeweb Markets | Alto Neuroscience, vs. Gerdau SA ADR |
Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |